{"organizations": [], "uuid": "08553a65ee18787329f185b70b86be782f5e07ad", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/dova-pharms-fda/fda-approves-dova-pharmas-blood-disorder-drug-idUSL3N1SS4H9", "country": "US", "domain_rank": 408, "title": "FDA approves Dova Pharma's blood disorder drug", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-21T18:19:00.000+03:00", "replies_count": 0, "uuid": "08553a65ee18787329f185b70b86be782f5e07ad"}, "author": "", "url": "https://www.reuters.com/article/dova-pharms-fda/fda-approves-dova-pharmas-blood-disorder-drug-idUSL3N1SS4H9", "ord_in_thread": 0, "title": "FDA approves Dova Pharma's blood disorder drug", "locations": [], "entities": {"persons": [{"name": "manas mishra", "sentiment": "none"}, {"name": "sharnya g", "sentiment": "none"}, {"name": "sai sachin ravikumar", "sentiment": "none"}], "locations": [{"name": "bengaluru", "sentiment": "none"}], "organizations": [{"name": "fda", "sentiment": "negative"}, {"name": "dova pharma", "sentiment": "negative"}, {"name": "u.s food and drug administration", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "dova pharmaceuticals inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 21, 2018 / 3:19 PM / Updated 28 minutes ago FDA approves Dova Pharma's blood disorder drug Reuters Staff 1 Min Read\nMay 21 (Reuters) - The U.S Food and Drug Administration has approved Dova Pharmaceuticals Incâ€™s drug to treat thrombocytopenia, or low blood platelet count, in patients with chronic liver disease, the agency said on Monday.\nThrombocytopenia is a common complication seen in chronic liver disease patients, caused by a low blood platelet count which may result in severe bleeding. (Reporting by Manas Mishra and Sharnya G in Bengaluru; Editing by Sai Sachin Ravikumar)", "external_links": [], "published": "2018-05-21T18:19:00.000+03:00", "crawled": "2018-05-21T19:01:50.008+03:00", "highlightTitle": ""}